Rituximab in Myasthenia Gravis: a real-world study using inverse probability of treatment weighting.

Saved in:
Bibliographic Details
Title: Rituximab in Myasthenia Gravis: a real-world study using inverse probability of treatment weighting.
Authors: Wang YL; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, VIC, Australia.; Department of Neurology, Alfred Health, Melbourne, VIC, Australia., Zhu C; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, VIC, Australia., Kapoor M; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, VIC, Australia.; Department of Neurology, Alfred Health, Melbourne, VIC, Australia., Cutter G; Department of Biostatistics, University of Alabama in Birmingham, Birmingham, AL, United States., Barnett-Tapia C; Division of Neurology, Department of Medicine, University Health Network, University of Toronto, Toronto, ON, Canada., Butzkueven H; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, VIC, Australia.; Department of Neurology, Alfred Health, Melbourne, VIC, Australia., Zhang W; Department of Neurology, Alfred Health, Melbourne, VIC, Australia., Lovas G; Department of Neurology, Jahn Ferenc Hospital, Budapest, Hungary., Rozsa C; Department of Neurology, Jahn Ferenc Hospital, Budapest, Hungary., Heckmann J; Neurology Research Group, Neuroscience Institute, University of Cape Town, Cape Town, South Africa., Blum S; Department of Neurology, Princess Alexandra Hospital, Wooloongabba, QLD, Australia., McLaughlin L; Department of Neurology, Princess Alexandra Hospital, Wooloongabba, QLD, Australia., Buzzard K; Department of Neurosciences, Box Hill Hospital, Box Hill, VIC, Australia.; Eastern Health Clinical School, Monash University, Box Hill, VIC, Australia., Foong YC; Depatment of Neurology, Royal Hobart Hospital, Tasmanian Health Service, Hobart, TAS, Australia.; MS Research Flagship, Menzies Institute of Medical Research, University of Tasmania, Hobart, TAS, Australia., Chroni E; Neuromuscular Unit, Department of Neurology, University of Patras, Patras, Greece., Veltsista D; Neuromuscular Unit, Department of Neurology, University of Patras, Patras, Greece., Cruse B; Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia.; Faculty of Medicine, Health and Dentistry, Department of Medicine (RMH), The University of Melbourne, Melbourne, VIC, Australia., Botrous M; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, VIC, Australia.; Department of Neurology, Alfred Health, Melbourne, VIC, Australia., Reddel S; Brain and Mind Centre, Camperdown, NSW, Australia., Monif M; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, VIC, Australia.; Department of Neurology, Alfred Health, Melbourne, VIC, Australia., van der Walt A; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, VIC, Australia.; Department of Neurology, Alfred Health, Melbourne, VIC, Australia.
Source: Frontiers in neurology [Front Neurol] 2026 Jul 02; Vol. 17, pp. 1882884. Date of Electronic Publication: 2026 Jul 02 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-2295
DOI:10.3389/fneur.2026.1882884